YIFAN PHARMACEUTICAL CO (SZSE:002019) Other Long Term Assets : ¥1,184 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Other Long Term Assets?

YIFAN PHARMACEUTICAL CO's other long-term assets for the quarter that ended in Mar. 2024 was ¥1,184 Mil.

YIFAN PHARMACEUTICAL CO's quarterly other long-term assets declined from Sep. 2023 (¥1,228 Mil) to Dec. 2023 (¥1,154 Mil) but then increased from Dec. 2023 (¥1,154 Mil) to Mar. 2024 (¥1,184 Mil).

YIFAN PHARMACEUTICAL CO's annual other long-term assets increased from Dec. 2021 (¥1,108 Mil) to Dec. 2022 (¥1,216 Mil) but then declined from Dec. 2022 (¥1,216 Mil) to Dec. 2023 (¥1,154 Mil).

YIFAN PHARMACEUTICAL CO Other Long Term Assets Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Other Long Term Assets Chart

YIFAN PHARMACEUTICAL CO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

993.87

1,058.15

1,108.28

1,216.36

1,153.68

YIFAN PHARMACEUTICAL CO Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															1,217.95	1,235.51	1,228.48	1,153.68	1,184.20

YIFAN PHARMACEUTICAL CO Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300

Website

https://en.yifanyy.com

YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.

Executives

Ye Yi Qun	Director
Zhang Da Wei	Executives
Geng Yu Hong	Executives
Feng De Qi	Directors, Directors, and Executives
Zhou Ben Yu	Director
Lin Xing	Directors, executives
Yu Hai Xia	Executives
Cheng Xian Feng	Directors, executives
Xu Guo Han	Supervisors
Cao Shi Mei	Director
Lin Guan Yu	Director
Zhang Lian Chun	Executives
Guo Xin Fu	Director
Zheng Shi Ming	Supervisors
Yin Hang Hua	Executives

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines